| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 70.4 | 53.6 | +31.3% |
| EBITDA | 19.8 | 12.2 | +62.1% |
| EBITDA margin | 28.1% | 22.8% | +5.4 pts |
| Profit before tax | 22.0 | 14.4 | +53.1% |
| Net profit | 16.3 | 10.2 | +59.3% |
| EPS | ₹5.07 | ₹3.18 | +59.4% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,306 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 211 | 211 | 84.3 | 159 | 90.8 | ||
| 1,094 | — | — | — | — | ||
| 232 | 215 | 175 | 191 | 225 | ||
| — | +22.9% | −8.4% | −15.0% | — | ||
| 51.7 | 44.2 | 45.9 | 42.7 | 61.9 | ||
| 22.3% | 20.5% | 26.2% | 22.4% | 27.5% | ||
| 49.1 | 41.0 | 43.2 | 40.5 | 60.4 | ||
| 56.3 | 50.3 | 42.5 | 39.0 | 50.7 | ||
| 24.3% | 23.3% | 24.3% | 20.4% | 22.5% | ||
| ₹17.55 | ₹16.94 | ₹13.25 | ₹12.95 | ₹15.80 | ||
| — | +27.9% | +2.3% | −18.0% | — | ||
| — | 87.2 | −72.0 | 67.9 | 60.3 | ||
| — | −0.3 | −6.7 | −4.6 | −5.0 | ||
| 86.9 | 86.9 | −78.7 | 63.3 | 55.3 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 1,305.7 | |
| - Cash, Equiv & ST Investments | 90.8 | 158.8 | 84.3 | 211.3 | 211.3 | |
| Enterprise Value | — | — | — | — | 1,094.4 | |
| Revenue | 225.1 | 191.3 | 175.3 | 215.5 | 232.2 | |
| Growth %, YoY | — | -15.0 | -8.4 | +22.9 | — | |
| EBITDA | 61.9 | 42.7 | 45.9 | 44.2 | 51.7 | |
| Margin % | 27.52 | 22.35 | 26.18 | 20.50 | 22.28 | |
| EBIT | 60.4 | 40.5 | 43.2 | 41.0 | 49.1 | |
| Net Income | 50.7 | 39.0 | 42.5 | 50.3 | 56.3 | |
| Margin % | 22.52 | 20.37 | 24.25 | 23.33 | 24.25 | |
| EPS, Adj (current shares) | 15.80 | 12.95 | 13.25 | 16.94 | 17.55 | |
| Growth %, YoY | — | -18.0 | +2.3 | +27.9 | — | |
| Cash from Operations | 60.3 | 67.9 | -72.0 | 87.2 | — | |
| Capital Expenditures | -5.0 | -4.6 | -6.7 | -0.3 | — | |
| Free Cash Flow | 55.3 | 63.3 | -78.7 | 86.9 | 86.9 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Indo Borax & Chemicals (NSE: INDOBORAX) had a market capitalisation of ₹1,307 crore at the 29 October 2026 close (₹407.30 a share), a PE ratio of 22.0 on the last four quarters' profit and a price-to-book ratio of 3.38. In FY26 its consolidated net profit was ₹54.4 crore on revenue of ₹215 crore; in Q1 FY27 (April–June 2026) it was ₹16.3 crore, up 59.3% year on year. It had no borrowings on 31 March 2026. Promoters held 38.41% of the shares on 30 September 2026.
Indo Borax & Chemicals' PE ratio is 22.0 at the 29 October 2026 close (₹407.30 a share): a market capitalisation of ₹1,307 crore divided by consolidated net profit of ₹59.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹54.4 crore) it is 24.0.
Indo Borax & Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹387 crore on 31 March 2026, up 15.2% from ₹335 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,307 crore at the 29 October 2026 close.
Indo Borax & Chemicals' book value per share was ₹120.47 on 31 March 2026: shareholders' equity of ₹387 crore divided by the 3.21 crore shares in issue, up 15.2% from ₹104.53 a year earlier. The share price at the 29 October 2026 close was ₹407.30.
Indo Borax & Chemicals' price-to-book (PB) ratio is 3.38 at the 29 October 2026 close: a market capitalisation of ₹1,307 crore divided by shareholders' equity (book value) of ₹387 crore on 31 March 2026. That is a book value of ₹120.47 per share against a share price of ₹407.30.
In FY26, Indo Borax & Chemicals' return on equity (ROE) was 15.1% and its return on capital employed (ROCE) was 11.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 13.5% and ROCE 13.6%.
Indo Borax & Chemicals' dividend yield is 9.82% at the 29 October 2026 close: dividends of ₹40 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹407.30. They were ₹40 on 21 July 2026 (special).
Indo Borax & Chemicals' market capitalisation was ₹1,307 crore at the 29 October 2026 close: 3.21 crore shares at ₹407.30 each.
Yes. Indo Borax & Chemicals had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹212 crore of cash, bank balances and current investments.
In 2026, Indo Borax & Chemicals has declared one dividend: ₹40 (special) with record date 21 July 2026.
Indo Borax & Chemicals' debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹387 crore. A year earlier, on 31 March 2025, it was 0.00.
Promoters held 38.41% of Indo Borax & Chemicals on 30 September 2026, unchanged from the previous quarter and down 12.39 percentage points from 50.80% a year earlier, according to the shareholding pattern filed with NSE.
Indo Borax & Chemicals has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
Indo Borax & Chemicals' basic earnings per share (EPS) were ₹15.67 in FY26, against ₹13.25 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹17.56.
In FY26, Indo Borax & Chemicals generated ₹87.2 crore of cash from operations and spent ₹29 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹86.9 crore. In FY25 it was −₹78.7 crore.
Indo Borax & Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 10 August 2026: consolidated net profit ₹16.3 crore, up 59.3% from ₹10.2 crore in Q1 FY26; revenue from operations ₹70.4 crore, up 31.3% year on year.
On 30 September 2026, Indo Borax & Chemicals' shares were held by promoters 38.41%, foreign portfolio investors (FII/FPI) 0.10%, domestic institutions (DII) 0.04% and retail and other non-institutional investors 61.44%. Over the year, FII holding was down 0.43 percentage points from 0.53% and DII holding was up 0.02 percentage points from 0.02%.
In FY26 (April 2025–March 2026), Indo Borax & Chemicals' consolidated net profit was ₹54.4 crore, up 27.9% from ₹42.5 crore in FY25, on revenue from operations of ₹215 crore (up 22.9%). Over three years, from FY23, net profit was up 7.2%.
At the 29 October 2026 closing prices, on FY26 net profit, Indo Borax & Chemicals' PE ratio is 24.0, the lowest of the four: Supreme Petrochem 40.8, Sumitomo Chemical India 30.5 and IG Petrochemicals 745.7, a peer average of 272.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Supreme Petrochem, Sumitomo Chemical India and IG Petrochemicals: Indo Borax & Chemicals' operating margin of 19.0% is the highest of the four (Supreme Petrochem 7.9%, Sumitomo Chemical India 18.7%, IG Petrochemicals 1.3%; peer average 9.3%); its return on equity of 15.1% is the second highest of the four (Supreme Petrochem 14.3%, Sumitomo Chemical India 17.3%, IG Petrochemicals 0.2%; peer average 10.6%).
In FY26, Indo Borax & Chemicals earned net profit of ₹54.4 crore on revenue of ₹215 crore, against ₹329 crore on ₹5,406 crore for Supreme Petrochem. Indo Borax & Chemicals' operating margin was 19.0% (Supreme Petrochem 7.9%) and its return on equity 15.1% (Supreme Petrochem 14.3%). At the 29 October 2026 close, Indo Borax & Chemicals' market capitalisation was ₹1,307 crore against ₹13,417 crore for Supreme Petrochem, and its PE ratio on FY26 profit 24.0 against 40.8.
From Indo Borax & Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.